Leukemia Diagnosis

Leukemia is a malignant disease originating from the hematopoietic system. Failure to diagnose and treat it early often leads to rapid disease progression, causing severe anemia, bleeding, and immune dysfunction that can be life-threatening. Through scientific and systematic examination and diagnosis, the disease type can be identified early, providing a critical basis for treatment.

Diagnostic Basis

1. Hematological examination
Complete blood count (CBC) testing is an important means of initial screening for leukemia. Abnormally high or low white blood cell counts, along with reduced red blood cell and platelet counts, are clinical signs suggestive of leukemia. Abnormal white blood cell morphology also indicates the possibility of disease.

2. Bone marrow aspiration and biopsy
Bone marrow aspiration directly observes bone marrow cell morphology to confirm the presence and proportion of leukemia cells. Biopsy further clarifies cell type, providing the basis for classification and staging, making it the gold standard for leukemia diagnosis.

3. Flow cytometry
Flow cytometry identifies abnormal cell subgroups through cell surface markers, helping distinguish between acute and chronic, lymphoid and myeloid leukemias, and guiding precise treatment strategies.

4. Chromosome and genetic testing
Chromosome analysis and molecular genetic testing reveal genetic abnormalities in leukemia cells, helping evaluate prognosis, select targeted therapies, and improve treatment outcomes.

5. Imaging examinations
Chest X-rays, ultrasound, and CT scans are used to evaluate whether organs such as lymph nodes, liver, and spleen are affected, aiding diagnosis and disease assessment.

Conclusion

Leukemia diagnosis relies on comprehensive evaluation from multiple examinations. Experts at United Life International Medical Center emphasize that early and accurate diagnosis provides the foundation for treatment, ensuring patients achieve better therapeutic outcomes and quality of life.